Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rabea Asleh

Showing results (1-10 of 120) with videos related to

Pageof 12
Sort By:
Heart (British Cardiac Society)|October 20, 2021
Persistent sex differences in outcomes after coronary heart disease: time to move from observation to actionRabea Asleh
Annals of Translational Medicine|January 8, 2019
Cardiovascular risk prediction in older adults with the use of biomarkersAlexandros Briasoulis, Rabea Asleh
Journal of Clinical Medicine|August 16, 2019
Utilization of Percutaneous Mechanical Circulatory Support Devices in Cardiogenic Shock Complicating Acute Myocardial Infarction and High-Risk Percutaneous Coronary InterventionsRabea Asleh, Jon R Resar
Vascular Health and Risk Management|February 27, 2007
In vivo and in vitro studies establishing haptoglobin as a major susceptibility gene for diabetic vascular diseaseRabea Asleh, Andrew P Levy
Antioxidants & Redox Signaling|September 23, 2009
Divergent effects of alpha-tocopherol and vitamin C on the generation of dysfunctional HDL associated with diabetes and the Hp 2-2 genotypeRabea Asleh, Andrew P Levy
JACC. Heart Failure|April 13, 2023
PET Assessment of Cardiac Allograft Vasculopathy After Heart Transplantation: Beyond Coronary Angiography and IVUSRabea Asleh, Sudhir S Kushwaha
Heart Rhythm|June 3, 2026
Haptoglobin, Hemolysis, and Renal Vulnerability After Pulsed Field Ablation: The Hemoglobin-Binding ReserveAndrew P Levy, Rabea Asleh
Current Opinion in Cardiology|January 4, 2021
Novel technologies in the management of heart failure with preserved ejection fraction: a promise during the time of disappointment from pharmacological approaches?Dean Nachman, Rabea Asleh, Offer Amir
European Journal of Heart Failure|May 13, 2022
Non-steroidal aldosterone receptor antagonism: a 'fine' treatment for heart failure patients?Rabea Asleh, Alexandros Briasoulis, Barry A Borlaug
The New England Journal of Medicine|April 15, 2011
Cholesterol efflux capacity and atherosclerosisRabea Asleh, Andrew P Levy, Shany Blum
Pageof 12

Showing results (1-10 of 120) with videos related to

Sort By:
Pageof 12
Heart (British Cardiac Society)|October 20, 2021
Persistent sex differences in outcomes after coronary heart disease: time to move from observation to actionRabea Asleh
Annals of Translational Medicine|January 8, 2019
Cardiovascular risk prediction in older adults with the use of biomarkersAlexandros Briasoulis, Rabea Asleh
Journal of Clinical Medicine|August 16, 2019
Utilization of Percutaneous Mechanical Circulatory Support Devices in Cardiogenic Shock Complicating Acute Myocardial Infarction and High-Risk Percutaneous Coronary InterventionsRabea Asleh, Jon R Resar
Vascular Health and Risk Management|February 27, 2007
In vivo and in vitro studies establishing haptoglobin as a major susceptibility gene for diabetic vascular diseaseRabea Asleh, Andrew P Levy
Antioxidants & Redox Signaling|September 23, 2009
Divergent effects of alpha-tocopherol and vitamin C on the generation of dysfunctional HDL associated with diabetes and the Hp 2-2 genotypeRabea Asleh, Andrew P Levy
JACC. Heart Failure|April 13, 2023
PET Assessment of Cardiac Allograft Vasculopathy After Heart Transplantation: Beyond Coronary Angiography and IVUSRabea Asleh, Sudhir S Kushwaha
Heart Rhythm|June 3, 2026
Haptoglobin, Hemolysis, and Renal Vulnerability After Pulsed Field Ablation: The Hemoglobin-Binding ReserveAndrew P Levy, Rabea Asleh
Current Opinion in Cardiology|January 4, 2021
Novel technologies in the management of heart failure with preserved ejection fraction: a promise during the time of disappointment from pharmacological approaches?Dean Nachman, Rabea Asleh, Offer Amir
European Journal of Heart Failure|May 13, 2022
Non-steroidal aldosterone receptor antagonism: a 'fine' treatment for heart failure patients?Rabea Asleh, Alexandros Briasoulis, Barry A Borlaug
The New England Journal of Medicine|April 15, 2011
Cholesterol efflux capacity and atherosclerosisRabea Asleh, Andrew P Levy, Shany Blum
Pageof 12